Reading these posts around removing the CEO because the stock price has gone down or things are delayed makes me feel like I'm back in preschool. You're on the speculative end of the market and in biotech, what did you really expect? Your due diligence should have factored these sort of announcements happening, (or lack thereof). To quote Peter Lynch, "Everyone has the brain power to make money in stocks. Not everyone has the stomach." If you can't handle it, you shouldn't be in it. My opinion of course.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-94
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
